Answers are grounded in this paper and cite their sources.
The paper analyzes the current scientific literature, including the results of clinical trials, meta-analyses and guidelines for the treatment of bipolar affective disorder (BAD) published in recent years. Modern diagnostic criteria, used scales for assessing the condition, as well as differential diagnosis with other mental disorders are considered. Modern hypotheses of the development of this disease, including genetic, biochemical and perinatal, are discussed. An overview of modern pharmacotherapy strategies for BAD is presented, including the use of mood stabilizers (lithium, valproates, carbamazepine), atypical antipsychotics, and antidepressants. The principles of individual selection of drug therapy, monitoring of side effects and prevention of relapses are described. The role of psychotherapy, in particular family-oriented therapy in the complex treatment of BAD is considered.
No takes yet. Share an insight, caveat, or question.
Skvorcov et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: